Clinical Trial

Endocan and Copeptin Serum Levels in Preterm Neonates With Respiratory Distress Syndrome

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated September 4, 2025 (before its estimated November 1, 2025 completion). Its status may not reflect the trial's current state.
Summary
This work aims to investigate and compare the levels of serum endocan and serum copeptin on the first day of life and correlate their levels to the severity of respiratory distress in preterm neonates suffering from respiratory distress syndrome.
Trial Details
NCT Number NCT07154134
Lead Sponsor Tanta University
Conditions Endocan, Copeptin, Serum, Preterm Neonates, Respiratory Distress Syndrome
Enrollment 40 participants
Start Date 2025-07-10
Primary Completion 2025-11-01 (estimated)
Study Completion 2025-11-01 (estimated)
Updated on ClinicalTrials.gov 2025-09-04